FDA Approval: ENLICITIDE (ENLICITIDE CHLORIDE) — Type 1 - New Molecular Entity
Multi-specialty
CPT procedure code
95957
Code definition
Code
95957
Code system
CPT (Current Procedural Terminology)
This CPT code is not in our curated reference. CPT codes are maintained by the American Medical Association (AMA). Full descriptions require an AMA license.
Category
—
Short description sourced from CMS publicly available fee schedule data. Full CPT descriptions are copyright AMA. Not a substitute for the official CPT codebook.
Latest reimbursement alerts
No policy changes are currently matched to 95957. Here are the latest changes across all codes.
Routine
FDA Approval: SUBVENITE (LAMOTRIGINE) — Type 3 - New Dosage Form
Neurology
Proposed LCD DL33317: External Breast Prostheses — DME MAC
DME
Proposed LCD DL33797: Oxygen and Oxygen Equipment — DME MAC
DME
LCD L35074: Heavy Metal Testing — Wellpoint Federal
Clinical Laboratory
LCD L37606: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases — Wellpoint Federal
Oncology
Audit documentation
Building an audit file that includes CPT 95957?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription
Get alerts when policy changes affect 95957
Free weekly digest — no subscription required.
Look up another code
Search ICD-10, HCPCS, or CPT codes with related reimbursement alerts.